Analysis of replication mechanism of hepatitis E virus using infection-permissive and -nonpermissive cell lines
Project/Area Number |
16K08825
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Virology
|
Research Institution | National Institute of Infectious Diseases |
Principal Investigator |
Ishii Koji 国立感染症研究所, 品質保証・管理部, 部長 (40280763)
|
Research Collaborator |
SHIOTA Tomoyuki
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | E型肝炎ウイルス / 複製機構 / 病原性 / 阻害剤 / ウィルス / 感染症 / 微生物 / 細胞・組織 / たん白質 |
Outline of Final Research Achievements |
The purpose of this study was to develop therapeutic agents for hepatitis E by identifying chemical compounds that inhibit hepatitis E virus (HEV) replication. Chemical libraries were screened for the inhibition of HEV replication using HEV replicon. Several compounds were shown to have strong activity to inhibit HEV replication. These compounds are promising agents for chemotherapy of hepatitis E.
|
Academic Significance and Societal Importance of the Research Achievements |
近年の研究から、E型肝炎は希少な輸入感染症ではなく、我が国においても常に流行の危険は存在すると考えられ、日本でも予防、治療研究への真剣な取り組みが必要になってきていると言える。HEVは慢性化しないため、薬剤としては急性期にウイルス増殖を阻害する薬剤が強く望まれる。構築したHEVレプリコンを用いてHEV増殖阻害剤のスクリーニングを行った化合物ライブラリには、すでに実用化されている薬剤のライブラリも存在するため、見出された化合物はすぐに急性E型肝炎治療薬として応用できる可能性がある。また、これらの阻害剤の阻害メカニズムの解析は、HEVの病原性の解析に重要な手がかりとなる可能性がある。
|
Report
(4 results)
Research Products
(38 results)
-
-
[Journal Article] A Cluster of Hepatitis A Infections Presumed to be Related to Asari Clams and Investigation of the Spread of Viral Contamination from Asari Clams2019
Author(s)
Tsukada R., Ono S., Kobayashi H., Wada Y., Nishizawa K., Fujii M., Takeuchi M., Kuroiwa K., Kobayashi Y., Ishii K. and Nakazawa H.
-
Journal Title
Japanese Journal of Infectious Diseases
Volume: 72
Issue: 1
Pages: 44-48
DOI
NAID
ISSN
1344-6304, 1884-2836
Year and Date
2019-01-31
Related Report
-
[Journal Article] Epidermal growth factor receptor is a host entry cofactor triggering hepatitis B virus internalization2019
Author(s)
M. Iwamoto, W. Saso, R. Sugiyama, K. Ishii, M. Ohki, S. Nagamori, R. Suzuki, H. Aizaki, A. Ryo, J-H Yun, S-Y Park, N. Ohtani, M. Muramatsu, S. Iwami, Y. Tanaka, C. Sureau, T. Wakita and K. Watashi
-
Journal Title
Proc. Natl. Acad. Sci. USA
Volume: 116
Issue: 17
Pages: 8487-8492
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
[Journal Article] Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling2017
Author(s)
Sugiyama R., Murayama A., Nitta S., Yamada N., Tasaka-Fujita M., Masaki T., Aly H. H., Shiina M., Ryo A., Ishii K., Wakita T. and Kato T.
-
Journal Title
Oncotarget
Volume: 9
Issue: 5
Pages: 5627-5640
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth2017
Author(s)
Li T.C., Yoshizaki S., Kataoka M., Ami Y., Suzaki Y., Doan Y.H., Haga K., Ishii K., Takeda N. and Wakita T.
-
Journal Title
Infection, Genetics and Evolution
Volume: 25
Pages: 153-159
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
[Journal Article] Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model2016
Author(s)
Yokokawa H., Higashino A., Suzuki S., Moriyama M., Nakamura N., Suzuki T., Suzuki R., Ishii K., Kobiyama K., Ishii KJ., Wakita T., Akari H. and Kato T.
-
Journal Title
Gut
Volume: in press
Issue: 2
Pages: 372-379
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy2016
Author(s)
Miyoshi M., Kakinuma S., Tanabe Y., Ishii K., Li T.C., Wakita T,, Tsuura Y., Watanabe H., Asahina Y., Watanabe M. and Ikeda T.
-
Journal Title
Internal Medicine
Volume: 55
Issue: 19
Pages: 2811-2817
DOI
NAID
ISSN
0918-2918, 1349-7235
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Ferret Hepatitis E Virus Infection Induces Acute Hepatitis and Persistent Infection in Ferrets2016
Author(s)
Li Tiancheng, Yang T, Sayaka Yoshizaki, Kataoka M, Ami Y, Suzaki Y, Kishida N, Shirakura M, Imai M, Asanuma H, Takeda N, Wakita T
-
Journal Title
Vet Microbiol
Volume: 183
Pages: 30-36
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
[Presentation] Identification of host kinases that regulate hepatitis B virus internalization.2018
Author(s)
Iwamoto M., Saso W., Sugiyama R., Ishii K., Suzuki R., Aizaki H., Ryo A., Ohtani N., Muramatsu M., Iwami S., Tanaka Y., Wakita T. and Watashi K.
Organizer
The 66th Annual Meeting of the Japanese Society for Virology
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Heat inactivation of Hepatitis E virus.2016
Author(s)
Imagawa T., Li T.C., Shiota T.,Yoshizaki S., Ishii K. and Wakita T.
Organizer
The 64th Annual Meeting of the Japanese Society for Virology
Place of Presentation
Sapporo, Japan
Year and Date
2016-10-23
Related Report
Int'l Joint Research
-
-